Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
169
NCT03997968
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 9, 2019
Completion: Dec 20, 2024